TAK-850
Sponsors
Takeda
Conditions
InfluenzaInfluenza InfectionInfluenza Prevention
Phase 1
Phase 2
Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants
CompletedNCT02555618
Start: 2015-09-30End: 2015-12-31Updated: 2016-12-29
A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants
WithdrawnNCT02713061
Start: 2016-03-31End: 2016-04-30Updated: 2016-08-25